Biorce logo

Biorce

Brand · Biotechnology Research

Company overview

Our mission is to dramatically reduce the time and cost of clinical trials. Aika, our AI platform, supports the various stages of the clinical trial lifecycle Phase 1-3, up until market approval. Clinical trials can take 11 years and cost ∼$6.2B to bring a drug to market. 57% face costly protocol amendments that add months of delay.We're changing that.With Aika, users can generate compliant and comprehensive documents (feasibility studies, entire protocols, application forms, financial documents, consent forms etc.) within minutes. Aika features nearly 100% of clinical trials published in the past 25 years (1M+ trials from official registries), 260K+ clinical trial protocols, peer-reviewed articles, regulatory guidelines and many more. Every recommendation is backed by verifiable sources. Every decision stays with the clinical experts. Human oversight guaranteed. Faster trials don’t mean more risk. With Aika, they mean smarter science. The impact:→ 50% faster protocol development→ $200K-$400K saved per avoided amendment→ Regulatory-ready outputs from day oneBuilt by clinical experts, for clinical experts.
Founded in 2024
Barcelona, Catalonia, ESP
72 employees (10 in marketing)

Salaries

Help build salary transparency at Biorce

Share your compensation anonymously to see full data.

Contribute

People

Hiring activity

Open marketing jobs over time

6 open now

Headcount trend

Company growth over the last 12 months

Headcount +323.8% year over year

Funding

Total funding

$9.6M

Last raise

$5.9M

Seed, 8 months ago

Funding history

Jul 2025

Seed Round Biorce · $5.9M

Dec 2024

Seed Round Biorce

Audience

Monthly website visitors
75.6K
Month over month+422.6%
Quarter over quarter+2117%
Top sourceDirect (45.7%)
Ad budget per month$0.0
Average search rank67.2
Traffic source mix
Direct
45.7%
Search
32.5%
Referral
15.9%
Social
4.5%
Paid referral
1.2%

LinkedIn followers

Follower count and growth

Total followers

9.3K

12-mo growth

+267.1%

Monthly growth

+55.7%

News

Links